FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1676095416> ?p ?o ?g. }

• W1676095416 endingPage "7" @default.
• W1676095416 startingPage "830" @default.
• W1676095416 abstract "The rates at which 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide are converted to phosphoramide mustard and acrolein were determined as a function of buffer composition, buffer concentration, and pH. Conversion of 4-hydroperoxycyclophosphamide to 4-hydroxycyclophosphamide in 0.5 M Tris buffer, pH 7.4, 37 degrees, was first-order (k = 0.016 min-1), but subsequent conversion of 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein under these conditions was negligible. Phosphoramide mustard and acrolein were readily generated from 4-hydroperoxycyclophosphamide or 4-hydroxycyclophosphamide when either of these agents was placed in phosphate buffer. Conversion of 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein was first-order with respect to 4-hydroxycyclophosphamide (k = 0.126 min-1 in 0.5 M phosphate buffer, pH 8, 37 degrees) as well as first-order with respect to phosphate serving as a catalyst. The rate-determining step in the reaction was pH dependent only insofar as the hydrogen ion concentration governed the relative amounts of monobasic and dibasic phosphate present. Pseudo-first-order rate constants were 0.045 M-1 min-1 for monobasic phosphate and 0.256 M-1 min-1 for dibasic phosphate. The role of phosphate in this reaction was as that of a bifunctional catalyst. The reaction was not subject to specific or general, acid or base, catalysis. Other bifunctional catalysts such as glucose-6-phosphate and bicarbonate also catalyzed the reaction, albeit less efficiently. Aldophosphamide apparently exists only transiently; its presence could not be established by 31P nuclear magnetic resonance spectroscopy. We conclude that, in the reaction sequence 4-hydroxycyclophosphamide leads to aldophosphamide leads to phosphoramide mustard + acrolein, the conversion of 4-hydroxycyclophosphamide to aldophosphamide is rate limiting and is subject to bifunctional catalysis; this reaction can proceed efficiently only in the presence of a bifunctional catalyst. Assuming that the oncotoxic specificity of cyclophosphamide resides with 4-hydroxycyclophosphamide and that its cytotoxic effect at therapeutic doses is largely mediated by phosphoramide mustard released within cells, these observations offer the possibility that the intracellular concentration of bifunctional catalysts, whether in the form of inorganic phosphates, organic phosphates, enzymes, or other species, serve as important determinants with regard to the oncotoxic potential and specificity of cyclophosphamide. Similarly, the concentration of bifunctional catalysis in the urine as well as the pH of the urine may be important with regard to the potential of cyclophosphamide to induce, via acrolein, hemorrhagic cystitis." @default.
• W1676095416 created "2016-06-24" @default.
• W1676095416 creator A5037083093 @default.
• W1676095416 creator A5040900629 @default.
• W1676095416 creator A5040985735 @default.
• W1676095416 date "1982-03-01" @default.
• W1676095416 modified "2023-10-12" @default.
• W1676095416 title "Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis." @default.
• W1676095416 cites W117874633 @default.
• W1676095416 cites W1530298292 @default.
• W1676095416 cites W1546824456 @default.
• W1676095416 cites W1558084593 @default.
• W1676095416 cites W1766100705 @default.
• W1676095416 cites W196377460 @default.
• W1676095416 cites W1964015820 @default.
• W1676095416 cites W2001610735 @default.
• W1676095416 cites W2013066631 @default.
• W1676095416 cites W2015638728 @default.
• W1676095416 cites W2041968020 @default.
• W1676095416 cites W2061833728 @default.
• W1676095416 cites W2068240047 @default.
• W1676095416 cites W2077623770 @default.
• W1676095416 cites W2082081767 @default.
• W1676095416 cites W2087137621 @default.
• W1676095416 cites W2105696980 @default.
• W1676095416 cites W2107193632 @default.
• W1676095416 cites W2125149754 @default.
• W1676095416 cites W2126028579 @default.
• W1676095416 cites W2154836084 @default.
• W1676095416 cites W2315624316 @default.
• W1676095416 cites W2325027257 @default.
• W1676095416 cites W2327390934 @default.
• W1676095416 cites W2408426611 @default.
• W1676095416 cites W2410530740 @default.
• W1676095416 cites W2410843759 @default.
• W1676095416 cites W2411536043 @default.
• W1676095416 cites W2412057738 @default.
• W1676095416 cites W2412795296 @default.
• W1676095416 cites W2473301557 @default.
• W1676095416 cites W3014843338 @default.
• W1676095416 cites W65886818 @default.
• W1676095416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7059981" @default.
• W1676095416 hasPublicationYear "1982" @default.
• W1676095416 type Work @default.
• W1676095416 sameAs 1676095416 @default.
• W1676095416 citedByCount "26" @default.
• W1676095416 countsByYear W16760954162015 @default.
• W1676095416 countsByYear W16760954162020 @default.
• W1676095416 countsByYear W16760954162022 @default.
• W1676095416 countsByYear W16760954162023 @default.
• W1676095416 crossrefType "journal-article" @default.
• W1676095416 hasAuthorship W1676095416A5037083093 @default.
• W1676095416 hasAuthorship W1676095416A5040900629 @default.
• W1676095416 hasAuthorship W1676095416A5040985735 @default.
• W1676095416 hasConcept C134337899 @default.
• W1676095416 hasConcept C13965031 @default.
• W1676095416 hasConcept C161790260 @default.
• W1676095416 hasConcept C177322064 @default.
• W1676095416 hasConcept C178790620 @default.
• W1676095416 hasConcept C185592680 @default.
• W1676095416 hasConcept C2777132085 @default.
• W1676095416 hasConcept C2780422782 @default.
• W1676095416 hasConcept C2780443040 @default.
• W1676095416 hasConcept C2781112554 @default.
• W1676095416 hasConceptScore W1676095416C134337899 @default.
• W1676095416 hasConceptScore W1676095416C13965031 @default.
• W1676095416 hasConceptScore W1676095416C161790260 @default.
• W1676095416 hasConceptScore W1676095416C177322064 @default.
• W1676095416 hasConceptScore W1676095416C178790620 @default.
• W1676095416 hasConceptScore W1676095416C185592680 @default.
• W1676095416 hasConceptScore W1676095416C2777132085 @default.
• W1676095416 hasConceptScore W1676095416C2780422782 @default.
• W1676095416 hasConceptScore W1676095416C2780443040 @default.
• W1676095416 hasConceptScore W1676095416C2781112554 @default.
• W1676095416 hasIssue "3" @default.
• W1676095416 hasLocation W16760954161 @default.
• W1676095416 hasOpenAccess W1676095416 @default.
• W1676095416 hasPrimaryLocation W16760954161 @default.
• W1676095416 hasRelatedWork W1676095416 @default.
• W1676095416 hasRelatedWork W1984977216 @default.
• W1676095416 hasRelatedWork W1994656267 @default.
• W1676095416 hasRelatedWork W1995887598 @default.
• W1676095416 hasRelatedWork W2091137211 @default.
• W1676095416 hasRelatedWork W2094371622 @default.
• W1676095416 hasRelatedWork W2336022319 @default.
• W1676095416 hasRelatedWork W2340137567 @default.
• W1676095416 hasRelatedWork W2905327869 @default.
• W1676095416 hasRelatedWork W3140468720 @default.
• W1676095416 hasVolume "42" @default.
• W1676095416 isParatext "false" @default.
• W1676095416 isRetracted "false" @default.
• W1676095416 magId "1676095416" @default.
• W1676095416 workType "article" @default.